Aclaris Therapeutics Announces Issuance of U.S. Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. AMC
10. META

Go back to Aclaris Therapeutics Announces Issuance of U.S. Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders
(NASDAQ: ACRS) Delayed: 5.57 +0.07 (1.27%)
Previous Close $5.50    52 Week High $33.88 
Open $5.55    52 Week Low $14.12 
Day High $5.62    P/E N/A 
Day Low $5.40    EPS $0.00 
Volume 1,521,431